Adrián González-González

Statistics

Publications

Citations

141

H-Index

Active since

2018

Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research(Current)

Universidad de Granada

Instituto de Investigación Biosanitaria de Granada

Cornell University

Methodist Hospital

Adrián González-González is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in oncology, cancer signaling pathways, and cancer stem cell signaling pathways.

ORCID

Publications per year

2018–2022

Publications

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling

Adrián González-González, Esperanza Muñoz‐Muela, Juan Antonio Marchal et al. · Clinical Cancer Research · 2018 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

Marina Cruz-Lozano, Adrián González-González, Juan Antonio Marchal et al. · European Journal of Nutrition · 2018 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +17

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

Araceli López-Tejada, Carmen Griñán‐Lisón, Adrián González-González et al. · International Journal of Biological Sciences · 2022 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–3 of 3